NDC 0527-1763

Dorzolamide Hydrochloride-Timolol Maleate

Dorzolamide Hydrochloride-timolol Maleate

Dorzolamide Hydrochloride-Timolol Maleate is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Lannett Company, Inc.. The primary component is Dorzolamide Hydrochloride; Timolol Maleate.

Product ID0527-1763_253f7644-0bcd-46ef-b70d-392f733de1cd
NDC0527-1763
Product TypeHuman Prescription Drug
Proprietary NameDorzolamide Hydrochloride-Timolol Maleate
Generic NameDorzolamide Hydrochloride-timolol Maleate
Dosage FormSolution
Route of AdministrationOPHTHALMIC
Marketing Start Date2014-12-17
Marketing CategoryANDA / ANDA
Application NumberANDA201998
Labeler NameLannett Company, Inc.
Substance NameDORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
Active Ingredient Strength20 mg/mL; mg/mL
Pharm ClassesCarbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0527-1763-73

1 BOTTLE, DROPPER in 1 CARTON (0527-1763-73) > 10 mL in 1 BOTTLE, DROPPER
Marketing Start Date2014-12-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0527-1763-73 [00527176373]

Dorzolamide Hydrochloride-Timolol Maleate SOLUTION
Marketing CategoryANDA
Application NumberANDA201998
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-17

Drug Details

Active Ingredients

IngredientStrength
DORZOLAMIDE HYDROCHLORIDE20 mg/mL

OpenFDA Data

SPL SET ID:167c5ae9-c354-4658-98ca-8b5b0939c841
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1923432
  • Pharmacological Class

    • Carbonic Anhydrase Inhibitor [EPC]
    • Carbonic Anhydrase Inhibitors [MoA]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.